Dr. Jeff Geschwind’s career blends innovation, clinical leadership, and scientific impact. As a leading authority in hepatocellular carcinoma, he advanced tumor visualization technologies, founded a glycolysis-targeting cancer drug company, and guided major oncology programs at Johns Hopkins, Yale, NAMSA, and USA Clinics Group. https://www.youtube.com/@jeffgeschwind6146